Mantle Cell Lymphoma News and Research

RSS
Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Second-quarter fiscal 2010 results announced by Pharmacyclics

Second-quarter fiscal 2010 results announced by Pharmacyclics

LRF's 2009 Mantle Cell Lymphoma Consortium report published

LRF's 2009 Mantle Cell Lymphoma Consortium report published

Updated clinical data of Calistoga Pharmaceuticals’ delta selective PI3K inhibitor presented

Updated clinical data of Calistoga Pharmaceuticals’ delta selective PI3K inhibitor presented

Researchers explore optimal induction therapies for managing blood cancer

Researchers explore optimal induction therapies for managing blood cancer

IMF to stage presentation on multiple myeloma at ASH annual meeting

IMF to stage presentation on multiple myeloma at ASH annual meeting

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Intense chemo wards off recurrence in half of mantle cell lymphoma patients after seven years

Intense chemo wards off recurrence in half of mantle cell lymphoma patients after seven years

Researchers aim to over-stress already taxed mantle cell lymphoma cells

Researchers aim to over-stress already taxed mantle cell lymphoma cells

Novel way to diagnose mantle cell lymphomas

Novel way to diagnose mantle cell lymphomas

Novel targeted therapy effectively treats acute leukemia

Novel targeted therapy effectively treats acute leukemia

New data show Enzastaurin's activity across multiple cancer cell lines

New data show Enzastaurin's activity across multiple cancer cell lines

Lilly launches phase III trial of Enzastaurin

Lilly launches phase III trial of Enzastaurin

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.